Related Experiment Video
Updated: Apr 30, 2026

10:08
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
Published on: February 24, 2021
6.0K
Pathway and network analysis in glioma with the partial least squares method
Wen-Tao Gu1, Shi-Xin Gu, Jia-Jun Shou
1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China
Asian Pacific Journal of Cancer Prevention : APJCP
|May 13, 2014
Summary
This study reveals 1,378 differentially expressed genes between high-grade gliomas. Key pathways and hub genes like ELAVL1 and FN1 were identified, offering insights into glioma prognosis and potential therapies.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Gene expression profiling is crucial for understanding glioma biology.
- Prior analyses often overlooked complex biological and environmental factors.
- Distinguishing between high-grade glioma subtypes (III vs. IV) requires advanced analytical methods.
Purpose of the Study:
- To investigate gene expression disparities between grade III and IV gliomas.
- To identify molecular pathways and genes associated with glioma prognosis.
- To leverage advanced statistical methods for a more comprehensive analysis.
Main Methods:
- Utilized the Gene Expression Omnibus (GEO) database for glioma expression data.
- Applied partial least squares (PLS) based analysis using R statistical software.
- Conducted survival and network analyses to identify prognostic markers and key genes.
Main Results:
- Identified 1,378 differentially expressed genes between grade III and IV gliomas.
- Four prognostic pathways identified: Prion diseases, colorectal cancer, cell adhesion molecules (CAMs), and PI3K-Akt signaling.
- Two significant hub genes, ELAVL1 and FN1, were pinpointed for their association with glioma.
Conclusions:
- The study provides novel insights into glioma pathogenesis and prognosis.
- Identified molecular targets may support future therapeutic strategies for gliomas.
- PLS-based analysis offers a robust approach for complex gene expression studies in oncology.

